Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 09, 2021 07:00 ET | Source: Entrada Therapeutics, Inc.

Entrada Therapeutics Reports Third Quarter 2021 Financial Results

Successful completion of upsized $208.7 million Initial Public Offering BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company...
November 18, 2021 08:00 ET | Source: Entrada Therapeutics, Inc.

Entrada Therapeutics to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference

BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients and become the world’s foremost intracellular...
November 02, 2021 16:26 ET | Source: Entrada Therapeutics, Inc.

Entrada Therapeutics Announces Closing of Initial Public Offering

BOSTON, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV™)...
October 28, 2021 22:21 ET | Source: Entrada Therapeutics, Inc.

Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering

BOSTON, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV™)...